Ondine Biomedical Inc (LON:OBIMF) | WebDisclosure

Basculer en Français

11335	Companies
251946	Keywords
181272	Articles
137748	Press releases

Headlines Articles Press releases Ondine Biomedical Inc

Home
Companies
Ondine Biomedical Inc

PRESS RELEASE

published on 04/15/2024 at 08:00, 2 years 6 months ago

Ondine Biomedical Inc. Announces 32% Fewer SSIs After Steriwave Replaced Mupirocin
Study at Mazankowski Alberta Heart Institute shows 32% reduction in cardiac infections with Steriwave replacing antibiotic standard. Significant cost savings and high compliance. Expert commentary available

Steriwave Cost Savings Mazankowski Alberta Heart Institute Cardiac Infections Antimicrobial Treatment
BRIEF

published on 04/10/2024 at 08:05, 2 years 7 months ago

Ondine Biomedical Inc.'s Steriwave Cleared for Use in HCA Healthcare UK Facilities

Antimicrobial Resistance Steriwave Healthcare-associated Infections HCA Healthcare UK Antibiotic Reduction
BRIEF

published on 04/10/2024 at 08:05, 2 years 7 months ago

Steriwave d'Ondine Biomedical Inc. autorisé à être utilisé dans les établissements HCA Healthcare au Royaume-Uni

Steriwave Infections Nosocomiales Résistance Aux Antimicrobiens HCA Healthcare Royaume-Uni Réduction Des Antibiotiques
PRESS RELEASE

published on 04/10/2024 at 08:00, 2 years 7 months ago

Ondine Biomedical Inc. Announces Steriwave Authorized for use by HCA UK
HCA UK authorizes Steriwave antimicrobial by Ondine Biomedical to combat healthcare-associated infections without inducing antimicrobial resistance. Approval allows wider adoption in healthcare facilities

Antimicrobial Resistance Healthcare Facilities Steriwave Ondine Biomedical HCA UK
BRIEF

published on 04/04/2024 at 08:05, 2 years 7 months ago

Ondine Biomedical Inc. Expands into ICU Market with Steriwave®

Antimicrobial Resistance Steriwave Ondine Biomedical Healthcare-associated Infections Intensive Care Unit
BRIEF

published on 04/04/2024 at 08:05, 2 years 7 months ago

Ondine Biomedical Inc. se développe sur le marché des soins intensifs avec Steriwave®

Steriwave Ondine Biomedical Infections Nosocomiales Résistance Aux Antimicrobiens Unité De Soins Intensifs
PRESS RELEASE

published on 04/04/2024 at 08:00, 2 years 7 months ago

Ondine Biomedical Inc. Announces Entry into ICU Market Expands Revenue Potential
Ondine Biomedical plans entry into ICU market following interest from Canadian Hospitals. The move aims to reduce infections with Steriwave® treatment without triggering antimicrobial resistance. Cost savings for hospitals expected

Antimicrobial Resistance Ondine Biomedical ICU Market Steriwave® Hospital Infections
BRIEF

published on 03/25/2024 at 08:05, 2 years 7 months ago

Ondine Biomedical Inc. Achieves Commercial Adoption of Steriwave in NHS Hospitals

Antimicrobial Resistance Ondine Biomedical Inc. Steriwave Surgical Site Infections NHS
BRIEF

published on 03/25/2024 at 08:05, 2 years 7 months ago

Ondine Biomedical Inc. parvient à l'adoption commerciale de Steriwave dans les hôpitaux du NHS

Steriwave Infections Du Site Opératoire NHS Ondine Biomédicale Inc. Résistance Aux Antimicrobiens
PRESS RELEASE

published on 03/25/2024 at 08:00, 2 years 7 months ago

Ondine Biomedical Inc. Announces First commercial adoption of Steriwave by the NHS
NHS hospitals adopt groundbreaking light-activated antimicrobial, Steriwave, to combat AMR and reduce surgical infections. Ondine Biomedical partners with NHS for further adoption

Steriwave Ondine Biomedical NHS Hospitals Light-activated Antimicrobial Surgical Infections

Accesswire

Published on 11/13/2026 at 17:25, 36 minutes ago

Sekur Private Data Raises SekurOne Price 25% to US$3,750 Per Year
Published on 11/13/2026 at 15:40, 2 hours 21 minutes ago

Vulcan Minerals Inc. - Review and Update on Affiliated Company Atlas Salt Inc.
Published on 11/13/2026 at 15:30, 2 hours 31 minutes ago

Road Access Completed Drill Program to Begin
Published on 11/13/2026 at 15:05, 2 hours 56 minutes ago

ACCESS Newswire Continues to Repurchase its Shares
Published on 11/13/2026 at 15:00, 3 hours 1 minute ago

Jaguar Health to Hold Investor Webcast November 17 Regarding Q3 2026 Financials & Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 11/13/2026 at 17:14, 47 minutes ago

Issue of Equity
Published on 11/13/2026 at 17:00, 1 hour 1 minute ago

Dividend payment ex-date of Eleving Group
Published on 11/13/2026 at 16:34, 1 hour 26 minutes ago

Holding(s) in Company
Published on 11/13/2026 at 16:26, 1 hour 35 minutes ago

Cairn Homes Plc: Holding(s) in Company
Published on 11/13/2026 at 16:15, 1 hour 46 minutes ago

REPLOID explores potential for Austrian farmers and foresters to save hundreds of millions of euros annually in mineral oil tax with locally produced biodiesel from insect fat

Les Echos

Published on 11/13/2026 at 17:45, 16 minutes ago

STEF : Droits de vote au 31-10-2026
Published on 11/13/2026 at 11:35, 6 hours 26 minutes ago

ENGIE and Google to partner on energy solutions for a potential data center project near Châteauroux, France
Published on 11/13/2026 at 11:35, 6 hours 26 minutes ago

ENGIE et Google s’associent pour développer les solutions énergétiques d’un projet de data center envisagé près de Châteauroux, en France
Published on 11/13/2026 at 08:00, 10 hours 1 minute ago

Résultats trimestriels au 30 septembre 2026 - ANR par action : 101,54 €, en progression de + 7,8 % sur 9 mois - Capitaux propres consolidés : 772 M€
Published on 11/12/2026 at 23:12, 18 hours 48 minutes ago

Belgrano continues the implementation of its public share buyback offer (OPRA)

View all LES ECHOS COMFI WIRE